ROYAL BANK OF CANADA - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 56 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
2,185
+9.2%
0.00%
Q2 2022$1,000
-66.7%
2,0000.0%0.00%
Q1 2022$3,000
-40.0%
2,0000.0%0.00%
Q4 2021$5,000
-16.7%
2,0000.0%0.00%
Q3 2021$6,000
-45.5%
2,000
-32.3%
0.00%
Q2 2021$11,000
-8.3%
2,956
-13.9%
0.00%
Q1 2021$12,000
+9.1%
3,435
+6.5%
0.00%
Q4 2020$11,000
+57.1%
3,224
+59.4%
0.00%
Q3 2020$7,000
-30.0%
2,023
-5.1%
0.00%
Q2 2020$10,000
-44.4%
2,131
-27.0%
0.00%
Q4 2019$18,0002,921
+41628.6%
0.00%
Q2 2019$070.00%
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders